Search - tctmd.com

Displaying 361 - 376 of 376

Sort: Relevancy | Date

Presentation TCT 2012

MR with Normal Left Ventricular Ejection Fraction: What Is It and How Should It Be Treated?

Presenter: Patrick O'Gara

October 23, 2012

Presentation TCT 2012

The Apica Left Ventricular Apical Access and Closure System: First-in-Human Use Experiences During TAVR

Presenter: Thomas Walther

October 22, 2012

Presentation TCT 2012

Allogenic Cells for Chronic Left Ventricular Dysfunction: The USA Experience and Beyond

Presenter: Emerson Perin

October 22, 2012

Presentation

Impact of Gender on 3-Month Outcome and Left Ventricular Remodeling After Transfemoral TAVR

Presenter: Verena Stangl

June 08, 2012

Presentation

Transcatheter Aortic Valve Implantation in Pts with Severe Left Ventricular Dysfunction

Presenter: Chiara Fraccaro

April 18, 2012

Presentation ACC 2012

Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Ischemic Heart Failure: The FOCUS-CCTRN Trial

Presenter: Emerson C. Perin

March 25, 2012

Presentation

RIME: Mitral Valve Annuloplasty Plus CABG Improves Functional Capacity and Promotes Reverse Left Ventricular (LV) Remodeling

Presenter: 202166|KMJ Chan

March 01, 2012

Presentation Cell Therapy 2012

Biomanipulation of Left Ventricular Wall Stress with a Novel Therapeutic Device: Assessment of Changes

Presenter: Randall J. Lee

January 24, 2012

Presentation TCT 2012

Tissue-Doppler Assessment of The Changes in Longitudinal Left and Right Ventricular Functions After Percutaneous Mitral Valvotomy

Presenter: Hosam Hasan-Ali, Ayman . Hassan

January 03, 2012

Presentation TCT 2012

Safety and Feasibility of Percutaneous Delivery of a Partial Left Ventricular Support Device (CircuLite® Synergy® Micro-Pump) in a Porcine Model

Presenter: Geng-Hua Yi, Yanping Cheng, Michael S. Aboodi, Armando Tellez, Gerard Conditt, Athanasios Peppas, Greg L. Kaluza, Rob Farnan, Arielle Drummond, Bryan Fritz, Gail Farnan, Daniel Burkhoff, Juan F. Granada

January 03, 2012

Presentation TCT 2012

Percutaneous Retrograde Left Ventricular Assist Support for Patients With Aortic Stenosis and Left Ventricular Dysfunction

Presenter: Claudia A. Martinez, Vikas Singh, Juan C. Londono, Mauricio G. Cohen, Carlos E. Alfonso, William W. O'Neill, Alan W. Heldman

January 03, 2012

Presentation TCT 2012

Percutaneous Left Ventricular Support With the Impella 2.5 Assist Device in Severe Cardiogenic Shock

Presenter: Markus Ferrari, Annemarie E. Engstr?m, Christian Jung, Klaus Empen, Paul Erne, St?phane Cook, Stephan Windecker, Martin W. Bergmann, Roland Klingenberg, Thomas F. L?scher, Michael Haude, Dierk Rulands, Christian Butter, Bengt Ullman, Laila Hellgren, Maria Grazia Modena, Giovanni Pedrazzini, Jose P. Henriques, Hans R. Figulla, Alexander Lauten

January 03, 2012

Presentation TCT 2012

Impact Of Pre-Hospital Activation Strategy On Revascularization Time, Left Ventricular Ejection Fraction and Mortality In Patients With ST-Elevation Myocardial Infarction.

Presenter: Sofia A. Horvath, Ke Xu, Francis Nwanyanwu, Richard Chan, Luis Correa, Nouri Nass, Abdul-Rahman Jaraki, David Jurkovich, Richard Kennedy, Paul A. Vignola, Roberto J. Cubeddu

January 03, 2012

Presentation TCT 2012

Epicardial Catheter-based Ventricular Reconstruction Restores Left Ventricular Rotation and Reverses Myocardial Remodeling in an Ovine Model of Left Ventricular Aneurysm

Presenter: Yanping Cheng, Michael S. Aboodi, Andrew Wechsler, Gerard Conditt, Athanasios Peppas, Greg L. Kaluza, Juan F. Granada, Kevin V. Bladel, Lon S. Annest, Geng-Hua Yi

January 03, 2012

Presentation TCT 2012

Clinical Outcome following Transcatheter Aortic Valve Implantation in Patients with Impaired Left Ventricular Systolic Function

Presenter: Robert M. van der Boon, Rutger-Jan Nuis, Nicolas M. van Mieghem, Luis M. Benitez, Robert-Jan van Geuns, Tjebbe W. Galema, Ron T. van Domburg, Patrick W. Serruys, Eduardo de Marchena, Marcel L. Geleijnse, Antonio E. Dager, Peter P. de Jaegere

January 03, 2012

Presentation TCT 2012

B-Type Natriuretic Peptide Predicts Improvement of Left Ventricular Function and Clinical Outcome After Balloon Aortic Valvuloplasty.

Presenter: Joelle Kefer, Jean-Marie Gapira, Amer Harmouch, Jim Reish, Jean Renkin

January 03, 2012

Advertisement

MR with Normal Left Ventricular Ejection Fraction: What Is It and How Should It Be Treated?

The Apica Left Ventricular Apical Access and Closure System: First-in-Human Use Experiences During TAVR

Allogenic Cells for Chronic Left Ventricular Dysfunction: The USA Experience and Beyond

Impact of Gender on 3-Month Outcome and Left Ventricular Remodeling After Transfemoral TAVR

Transcatheter Aortic Valve Implantation in Pts with Severe Left Ventricular Dysfunction

Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Ischemic Heart Failure: The FOCUS-CCTRN Trial

RIME: Mitral Valve Annuloplasty Plus CABG Improves Functional Capacity and Promotes Reverse Left Ventricular (LV) Remodeling

Biomanipulation of Left Ventricular Wall Stress with a Novel Therapeutic Device: Assessment of Changes

Tissue-Doppler Assessment of The Changes in Longitudinal Left and Right Ventricular Functions After Percutaneous Mitral Valvotomy

Safety and Feasibility of Percutaneous Delivery of a Partial Left Ventricular Support Device (CircuLite® Synergy® Micro-Pump) in a Porcine Model

Percutaneous Retrograde Left Ventricular Assist Support for Patients With Aortic Stenosis and Left Ventricular Dysfunction

Percutaneous Left Ventricular Support With the Impella 2.5 Assist Device in Severe Cardiogenic Shock

Impact Of Pre-Hospital Activation Strategy On Revascularization Time, Left Ventricular Ejection Fraction and Mortality In Patients With ST-Elevation Myocardial Infarction.

Epicardial Catheter-based Ventricular Reconstruction Restores Left Ventricular Rotation and Reverses Myocardial Remodeling in an Ovine Model of Left Ventricular Aneurysm

Clinical Outcome following Transcatheter Aortic Valve Implantation in Patients with Impaired Left Ventricular Systolic Function

B-Type Natriuretic Peptide Predicts Improvement of Left Ventricular Function and Clinical Outcome After Balloon Aortic Valvuloplasty.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content